Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
Tel: |
18818260767 |
Email: |
sales@chemegen.com |
Products Intro: |
Product Name:SR-318 CAS:2413286-32-3 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
1H-Pyrazole-4-carboxamide, 5-amino-N-[[4-[[(3-cyclohexylpropyl)amino]carbonyl]phenyl]methyl]-1-phenyl- manufacturers
- SR-318
-
- $53.00 / 5mg
-
2024-11-19
- CAS:2413286-32-3
- Min. Order:
- Purity: 99.53%
- Supply Ability: 10g
- SR-318
-
- $53.00 / 5mg
-
2024-11-19
- CAS:2413286-32-3
- Min. Order:
- Purity: 99.53%
- Supply Ability: 10g
|
| 1H-Pyrazole-4-carboxamide, 5-amino-N-[[4-[[(3-cyclohexylpropyl)amino]carbonyl]phenyl]methyl]-1-phenyl- Basic information |
Product Name: | 1H-Pyrazole-4-carboxamide, 5-amino-N-[[4-[[(3-cyclohexylpropyl)amino]carbonyl]phenyl]methyl]-1-phenyl- | Synonyms: | 1H-Pyrazole-4-carboxamide, 5-amino-N-[[4-[[(3-cyclohexylpropyl)amino]carbonyl]phenyl]methyl]-1-phenyl-;SR-318;anti-inflammatory,SR 318,TNFR,anti-cancer,p38 MAPK,Inhibitor,inhibit,whole,TNF Receptor,SR-318,SR318,p38α/β,Tumor Necrosis Factor Receptor,blood;SR-318, 10 mM in DMSO | CAS: | 2413286-32-3 | MF: | C27H33N5O2 | MW: | 459.58 | EINECS: | | Product Categories: | | Mol File: | 2413286-32-3.mol | ![1H-Pyrazole-4-carboxamide, 5-amino-N-[[4-[[(3-cyclohexylpropyl)amino]carbonyl]phenyl]methyl]-1-phenyl- Structure](CAS/20200611/GIF/2413286-32-3.gif) |
| 1H-Pyrazole-4-carboxamide, 5-amino-N-[[4-[[(3-cyclohexylpropyl)amino]carbonyl]phenyl]methyl]-1-phenyl- Chemical Properties |
Boiling point | 732.0±60.0 °C(Predicted) | density | 1.24±0.1 g/cm3(Predicted) | storage temp. | 2-8°C | solubility | DMSO:40.0(Max Conc. mg/mL);87.03(Max Conc. mM) | form | A solid | pka | 13.10±0.46(Predicted) | color | White to off-white |
| 1H-Pyrazole-4-carboxamide, 5-amino-N-[[4-[[(3-cyclohexylpropyl)amino]carbonyl]phenyl]methyl]-1-phenyl- Usage And Synthesis |
Biological Activity | SR-318 is a potent and selective type-II inhibitor th at targets p38α/β in an inactive DFG-out conformation with good kinome selectivity (p38α/β IC50 = 5/39 nM by radiometric kinase assay). SR-318 selectively inhibits p38α/β by cell-based NanoBRET assay (IC50 = 3.7 nM/p38α, 10 nM/p38β, 0.91 μM/ZAK, ≥3 μM/DDR1, DDR2, KIT, MYLK4, RSK4) and effectively blocks LPS-induced TNF-α release in human whole blood (IC50 = 283 nM). SR-321 is an inactive structural analog and the recommended negative control compound. |
| 1H-Pyrazole-4-carboxamide, 5-amino-N-[[4-[[(3-cyclohexylpropyl)amino]carbonyl]phenyl]methyl]-1-phenyl- Preparation Products And Raw materials |
|